News
KMSTF
0.640
NaN%
--
NLS Pharmaceutics to execute 1-for-10 reverse share split
Seeking Alpha · 10/29/2025 10:22
Weekly Report: what happened at KMSTF last week (0908-0912)?
Weekly Report · 09/15/2025 10:17
Weekly Report: what happened at KMSTF last week (0901-0905)?
Weekly Report · 09/08/2025 10:19
Weekly Report: what happened at KMSTF last week (0825-0829)?
Weekly Report · 09/01/2025 10:15
Weekly Report: what happened at KMSTF last week (0818-0822)?
Weekly Report · 08/25/2025 10:22
Weekly Report: what happened at KMSTF last week (0811-0815)?
Weekly Report · 08/18/2025 10:17
Weekly Report: what happened at KMSTF last week (0804-0808)?
Weekly Report · 08/11/2025 10:21
Weekly Report: what happened at KMSTF last week (0728-0801)?
Weekly Report · 08/04/2025 10:23
Weekly Report: what happened at KMSTF last week (0721-0725)?
Weekly Report · 07/28/2025 10:24
Weekly Report: what happened at KMSTF last week (0714-0718)?
Weekly Report · 07/21/2025 10:17
Weekly Report: what happened at KMSTF last week (0707-0711)?
Weekly Report · 07/14/2025 10:22
Weekly Report: what happened at KMSTF last week (0630-0704)?
Weekly Report · 07/07/2025 10:18
Weekly Report: what happened at KMSTF last week (0623-0627)?
Weekly Report · 06/30/2025 10:21
Weekly Report: what happened at KMSTF last week (0616-0620)?
Weekly Report · 06/23/2025 10:17
Weekly Report: what happened at KMSTF last week (0609-0613)?
Weekly Report · 06/16/2025 10:21
Weekly Report: what happened at KMSTF last week (0602-0606)?
Weekly Report · 06/09/2025 10:22
Weekly Report: what happened at KMSTF last week (0526-0530)?
Weekly Report · 06/02/2025 10:27
Weekly Report: what happened at KMSTF last week (0519-0523)?
Weekly Report · 05/26/2025 10:26
Weekly Report: what happened at KMSTF last week (0512-0516)?
Weekly Report · 05/19/2025 10:21
Weekly Report: what happened at KMSTF last week (0505-0509)?
Weekly Report · 05/12/2025 10:22
More
Webull provides a variety of real-time KMSTF stock news. You can receive the latest news about Kadimastem through multiple platforms. This information may help you make smarter investment decisions.
About KMSTF
Kadimastem Ltd is an Israel-based regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics, primarily for diabetes and neurodegenerative disorders. The Company’s technology enables the differentiation of stem cells into insulin secreting beta cells, as well as a range of neural cells (including Oligodendrocytes, Astrocytes). The Company produces islet-like clusters that show glucose-stimulated insulin secretion. In addition, the Company is partnering with pharmaceutical companies interested to screen potential drug compounds (hit-lead, lead optimization) on its stem-cell derived cells, primarily oligodendrocytes and astrocytes.